In a patient with grade 1 diastolic dysfunction, normal left ventricular size, normal left atrial volume index, low BNP and NT‑proBNP, an E/e′ of approximately 9 (rising), and a low peak velocity‑time integral (~22 cm), does grade 1 indicate that the heart is working harder and less efficiently, and could increased afterload be the primary contributor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Grade 1 Diastolic Dysfunction: Interpretation and Clinical Significance

Grade 1 diastolic dysfunction indicates impaired myocardial relaxation with normal or low left atrial pressure at rest, not necessarily a heart working "harder" or "less efficiently" in the traditional sense. 111

Understanding the Physiology

Your patient's profile presents a classic picture of Grade 1 diastolic dysfunction with reassuring hemodynamics:

  • Normal filling pressures: The E/e' of 9.2 (below the cutoff of >14 for elevated LAP), normal LAVI of 21.1 mL/m² (well below 34 mL/m²), and remarkably low natriuretic peptides (NT-proBNP <36 pg/mL) all confirm that left atrial pressure is normal or low 111

  • The fundamental abnormality: Grade 1 dysfunction reflects delayed myocardial relaxation, not increased myocardial work or reduced efficiency in generating cardiac output. The heart muscle takes longer to relax during early diastole, but this does not mean it's working harder to deliver output 11

Addressing Your Specific Concerns

Is the Heart Working Harder?

No, not in the way you're conceptualizing it. The low VTI (0.222m or 22.2 cm) actually suggests reduced stroke volume, which could indicate:

  • Reduced preload (the heart isn't filling as robustly due to impaired relaxation)
  • Potentially reduced cardiac output reserve
  • This is not the same as the heart straining to maintain output

The serially low BNP/NT-proBNP levels are particularly telling—these biomarkers rise with ventricular wall stress and volume overload. Your patient's values are essentially normal, arguing against significant myocardial strain 234

Afterload Considerations

Afterload could absolutely be a primary contributor, and this is an astute observation. Here's the algorithmic approach to assess this:

Evaluate for increased afterload:

  • Blood pressure control: Is systemic hypertension present or inadequately controlled? This is the most common cause of Grade 1 dysfunction 5
  • Arterial stiffness: Consider pulse pressure, pulse wave velocity if available
  • LV geometry: Check for concentric remodeling or LV hypertrophy on echo (you mention normal LV cavity volume, but what about wall thickness and relative wall thickness?)
  • Aortic valve: Any aortic stenosis, even mild?

The 2016 ASE/EACVI guidelines specifically note that pathologic LV hypertrophy is consistent with diastolic dysfunction and elevated afterload is a primary driver 15

Clinical Significance and Trajectory

The "Trending Higher" E/e' Concern

Your observation that E/e' is "trending higher at 9.2" warrants attention. While still below pathologic thresholds, Grade 1 dysfunction can progress:

  • Grade 1 is not benign: Research shows that even with normal natriuretic peptides, patients with Grade 1 dysfunction have 2.7-fold higher risk of mortality or HF readmissions compared to those with normal diastolic function 6

  • The progression pathway: Grade 1 can evolve to Grade 2 (pseudonormalization with elevated LAP) if the underlying cause (typically afterload excess) isn't addressed 11

  • Exercise unmasking: The most appropriate next step for Grade 1 dysfunction with unexplained symptoms is diastolic stress testing. Patients with Grade 1 at rest may develop elevated filling pressures with exercise (E/e' >14, TR velocity >2.8 m/sec) 11

Efficiency vs. Effectiveness

The heart is not "less efficient" in Grade 1 dysfunction—it's achieving adequate cardiac output at rest with normal filling pressures. However:

  • Reduced reserve capacity: The impaired relaxation limits the heart's ability to augment cardiac output with increased demand 1
  • The low VTI: This suggests the heart may already be operating with reduced stroke volume, potentially compensating with heart rate to maintain output
  • Preserved CO reserve mechanism: Studies show that patients with Grade 1 dysfunction and normal natriuretic peptides maintain cardiac output reserve during exercise, but only at the cost of higher left ventricular transmural pressure 6

Practical Management Implications

Focus on afterload reduction:

  1. Optimize blood pressure control (target <130/80 mmHg)
  2. Address contributing factors: obesity, diabetes, metabolic syndrome
  3. Consider ACE inhibitors or ARBs—these have shown benefit in improving diastolic parameters in hypertensive patients 5

Monitor for progression:

  • Serial natriuretic peptides (yours are reassuringly low now)
  • Repeat echo if symptoms develop or E/e' continues trending upward
  • Consider stress echo if exertional symptoms emerge 11

Key Caveats

  • Age matters: NT-proBNP increases with age, but <36 pg/mL is normal across all age groups 78
  • The E/A ratio matters: You didn't mention this, but if E/A ≤0.8 with peak E velocity ≤50 cm/sec, this confirms Grade 1 with normal LAP 11
  • Not "age-appropriate": While Grade 1 dysfunction becomes more prevalent with aging, it represents pathology, not normal aging 5

Your patient has early diastolic dysfunction with normal hemodynamics—the focus should be on identifying and treating the underlying cause (likely increased afterload) rather than viewing this as a heart working harder to maintain output.

References

Research

B-type natriuretic peptide level in the diagnosis of asymptomatic diastolic dysfunction.

Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2007

Related Questions

I have grade 1 diastolic dysfunction and mild stable concentric left‑ventricular hypertrophy, no symptoms, and an NT‑proBNP < 36 pg/mL; what management and follow‑up should I pursue?
What is the best approach to diagnose and manage a patient with normal BNP levels, unmeasured NT-proBNP levels, grade 1 diastolic dysfunction, low stroke volume index, mild pitting edema, and bilateral partial numbness of the toes?
What does an elevated NT‑proBNP indicate in a 73‑year‑old man with a preserved ejection fraction of 60‑65% and grade 1 diastolic dysfunction?
In a patient with grade 1 diastolic dysfunction, do B-type natriuretic peptide levels below 100 pg/mL and N-terminal pro‑B‑type natriuretic peptide levels below 300 pg/mL reliably exclude clinically overt heart failure?
What is the next treatment plan for a patient with grade 1 diastolic dysfunction, an Ejection Fraction (EF) of 55 to 60%, mild aortic valve calcification with moderate restricted opening, moderate mitral valve stenosis, and mild mitral valve regurgitation, who has remained stable over the past 3 years with consistent echocardiogram results?
Can ciprofloxacin‑dexamethasone ear drops be given when the tympanic membrane is not visualized due to cerumen obstruction?
Is it safe to combine carvedilol, losartan, and amlodipine for blood pressure and heart failure management, and what dosing and monitoring are recommended?
Should an 87-year-old man with heart failure, atrial fibrillation, coronary artery disease, a permanent pacemaker, chronic obstructive pulmonary disease, severe anemia (hemoglobin 7.8 g/dL, down from 9.7 g/dL one month ago), shortness of breath, and who is taking amiodarone, clopidogrel, and apixaban (Eliquis) be sent to the emergency department?
What essential history and physical examination should be performed for a patient with a chronic obstructive pulmonary disease (COPD) exacerbation?
In a patient with coronary artery disease who has a mixed‑density plaque in the right coronary artery with moderate stenosis on coronary computed tomography angiography (CCTA) and a negative fractional flow reserve computed tomography (FFR‑CT), what is the next management step?
Can propranolol be prescribed together with topiramate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.